Back to Search
Start Over
Ibrutinib combined with gemcitabine-vinorelbine for primary refractory non-Hodgkin lymphoma.
- Source :
-
Blood research [Blood Res] 2023 Dec 31; Vol. 58 (4), pp. 234-237. Date of Electronic Publication: 2023 Nov 15. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 2287-979X
- Volume :
- 58
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Blood research
- Publication Type :
- Editorial & Opinion
- Accession number :
- 37964656
- Full Text :
- https://doi.org/10.5045/br.2023.2023182